Fresenius Kabi Deutschland GmbH

Tweet this page
Registration as it was on 19 Feb 2024
How to read and use this data card.
Download this datacard


Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

1 Fte (3)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    Fresenius Kabi Deutschland GmbH

    EU Transparency Register

    130305227617-65 First registered on 29 Jun 2017

    Goals / Remit

    All meaningful care comes down to people with the experience, expertise, and compassion to make a difference in the lives of those facing challenging situations. For us, care is a fundamental obligation, mission, and daily source of inspiration. It is the momentum that pushes us forward to help elevate the quality of life for both caregivers and those who need it most: critically and chronically ill patients. By providing essential medicines and technologies for infusion, transfusion, and medical nutrition, we are helping advance the future of healthcare, making it even more accessible, reliable, and in tune with current and future needs.
    Fresenius Kabi employs over 42,000 people worldwide.
    Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA healthcare group.

    Main EU files targeted

    Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical and Biosimilars legislation, EU Trade Policy, European external trade agenda, Pharmaceuticals in the environment, global health.


    Head Office
    Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1
    Bad Homburg 61352
    EU Office
    Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1
    Bad Homburg 61352


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 21 Apr 2024

    Name Start date End Date
    Mr Matthew TURNER 11 Feb 2023 11 Feb 2024
    Mr Stefan KOLB 20 Jan 2023 20 Jan 2024
    Mr Hrishikesh KULKARNI 24 Mar 2022 24 Mar 2023
    Mr Matthew TURNER 05 Nov 2019 31 Oct 2020
    Mr Stefan KOLB 10 Oct 2019 01 Nov 2020
    Mr David M JAUCH 23 Oct 2018 23 Oct 2019

    Complementary Information

    Other persons are involved, but less than 10%.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Companies & groups

  • Networking


    Medicines for Europe, Medical Nutrition International, AMR Industry Alliance

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Communication activities


    Other activities

    Fresenius Kabi is cooperating with the institutions of the European Union to support policies that improves patient access to affordable medicines.

  • Meetings


    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: All information below comes from European Commission web pages.

Download this datacard